logo_microbiom_science_days_rgb

September 19/21 2019 – Hotel Kempinski, Berchtesgaden

Thursday, September 19th

  Dinner at a typical German “Almhütte”  
18:00 Start of the hiking trip
18:30 Bus departure to the “Almhütte”

 


Friday, September 20th

  Welcome  
09:00 09:10 Welcome and Introduction
09:10 10:30 Introduction round
10:30 – 11:00 Coffee Break
  Population studies and big data in microbiome research  
11:00 11:25 Global evolution and preservation of human gut bacteria Mathieu Groussin, Cambridge/Massachusetts
11:25 11:50 Obese individuals with and without Type 2 Diabetes Show Different Gut Microbial Functional Capacity and Composition Andre Franke, Kiel
11:50 12:20 A gut choice: and how the gut tastes calories Diego V. Bohórquez, Durham/North Carolina
Winston Liu
12:20 12:50 Drug-Microbiome-Interaction: General considerations and examples from human studies Vanessa Stadlbauer-Köllner, Graz
Angela Horvath
12:50 13:20 Discussion round
13:20 – 14:20 Buffet Lunch
  Metabolites and Immunometabolism  
14:20 14:50 Identification of host-microbial metabolite interactions for therapy response prediction in IBD Stefan Schreiber, Kiel
Konrad Aden
14:50 15:15 The Role of Secondary Bile Acids in Intestinal Inflammation Sidhartha Sinha, Stanford
15:15 15:40 Role of Indoleamine 2, 3-dioxygenase in metabolic diseases through gut microbiota Soraya Taleb, Paris
15:40– 16:00 Coffee Break  
  Metabolites and Immunometabolism  
16:00 16:30 Energy metabolism and hormones – news from the gut Barbara Obermayer-Pietsch, Graz
Valentin Borzan
16:30 17:00 Latest developments in metametabolomics of gut microbiomes Philippe Schmitt-Kopplin, München
Alesia Walker
17:00 17:30 Discussion round
19:30 Dinner at Le Ciel

 

 

Saturday, September 21st

  The microbiome in cancer diagnosis and treatment  
09:00 09:30 The intestinal microbiota as diagnostic and therapeutic factor in colorectal carcinoma Michael Scharl, Zürich
Ana Montalban-Arques
09:30 10:00 Licensing of Treatment Response- do microbiota matter in cancer therapy ? Philip Rosenstiel, Kiel
Felix Sommer
10:00 10:30 Discussion Round
10:30– 11:00 Coffee Break
  Microbiota – bacteria and beyond  
11:00 11:30 The intestinal and biliary microbiome in the pathogenesis of primary sclerosing cholangitis (PSC) Christoph Schramm, Hamburg
Corinna Bang
11:30 11:55 Gut-Liver-Axis in the pathophysiology of decompensated liver cirrhosis and acute-on-chronic liver failure (ACLF) Jonel Trebicka, Frankfurt
11:55 12:25 Translating microbiota research into therapies for liver disease Bernd Schnabl, San Diego
Sonja Lang
12:25 12:50 Mapping Microbiomes at the Micron Scale Gary Borisy, Cambridge/Massachusetts
12:50 13:30 Discussion round/Final discussion/closing remarks
13:30 Buffet Lunch

 

► Download program here